Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gamma-aminobutyric acid type A (GABA_A) receptor α1βδ subtype is a specific heteropentameric ligand-gated ion channel typically composed of two α1 subunits, two β subunits (such as β2 or β3), and one δ subunit (nih.gov, 2025). Unlike the more prevalent synaptic αβγ isoforms that mediate rapid phasic inhibition, α1βδ receptors are primarily localized to extrasynaptic and perisynaptic membranes, where they mediate a persistent "tonic" inhibitory current that regulates the baseline excitability of neurons (nih.gov, 2025; wikipedia.org, 2024). This subtype is characterized by a high affinity for GABA and slow desensitization, allowing it to respond to low ambient concentrations of the neurotransmitter in the extracellular space (nih.gov, 2025). Pharmacologically, α1βδ receptors are distinguished by their insensitivity to classical benzodiazepines and their high sensitivity to neurosteroids (e.g., allopregnanolone, ganaxolone), ethanol, and the selective agonist gaboxadol (nih.gov, 2025). Dysregulation of α1βδ-mediated tonic inhibition is implicated in various neurological and psychiatric conditions, including epilepsy, anxiety, and postpartum depression (nih.gov, 2025). Consequently, it serves as a significant therapeutic target for the development of novel anticonvulsants, sedatives, and antidepressants aimed at restoring inhibitory balance in the central nervous system.
Positive allosteric modulation and direct agonism of the chloride ion channel
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid type A receptor alpha1-beta-delta subtype (GABA_A receptor α1βδ).